2021年7月20日，歐盟食品安全局（EFSA）就審查吡唑萘菌胺（isopyrazam）的現有最大殘留水平發布意見。
根據歐盟委員會第396/2005號法規第12章，歐盟食品安全局審查了吡唑萘菌胺的最大殘留限量。盡管沒有發現吡唑萘菌胺對消費者有明顯的風險，但缺少監管框架要求的一些信息。因此，消費者風險評估僅被認為是指示性的，EFSA提出的一些MRL建議仍需風險管理者進一步考慮。部分原文報道如下：
According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance isopyrazam. To assess the occurrence of isopyrazam residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Commission Regulation (EU) No 188/2011, the MRLs established by the Codex Alimentarius Commission as well as the import tolerances and European authorisations reported by Member States (including the supporting residues data). based on the assessment of the available data, MRL proposals were derived and a consumer risk assessment was carried out. Although no apparent risk to consumers was identified, some information required by the regulatory framework was missing. Hence, the consumer risk assessment is considered indicative only and one MRL proposal derived by EFSA still requires further consideration by risk managers.
根據歐盟委員會第396/2005號法規第12章，歐盟食品安全局審查了吡唑萘菌胺的最大殘留限量。盡管沒有發現吡唑萘菌胺對消費者有明顯的風險，但缺少監管框架要求的一些信息。因此，消費者風險評估僅被認為是指示性的，EFSA提出的一些MRL建議仍需風險管理者進一步考慮。部分原文報道如下：
According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance isopyrazam. To assess the occurrence of isopyrazam residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Commission Regulation (EU) No 188/2011, the MRLs established by the Codex Alimentarius Commission as well as the import tolerances and European authorisations reported by Member States (including the supporting residues data). based on the assessment of the available data, MRL proposals were derived and a consumer risk assessment was carried out. Although no apparent risk to consumers was identified, some information required by the regulatory framework was missing. Hence, the consumer risk assessment is considered indicative only and one MRL proposal derived by EFSA still requires further consideration by risk managers.
